Evidence of PAX5 involvement in lymphomas paints it mainly as secondary player in pathogenic processes; however, its genetic alterations could be implicated in the development and progression of diffused large B-cell lymphoma (DLBCL), Anaplastic Large Cell Lymphoma (ALCL), and Mantle cell lymphoma (MCL). Here, PAX5 is linked to lymphoma.